Fig. 2From: Pharmacokinetics and brain distribution of the therapeutic peptide liraglutide by a novel LC–MS/MS analysisRepresentative chromatograms of liraglutide (left) and IS (right) obtained from A blank plasma, B blank brain tissue, C LLOQ concentration of liraglutide and IS in the plasma, D LLOQ concentration of liraglutide and IS in the brain tissue, E ULOQ concentration of liraglutide and IS in the plasma, and F ULOQ concentration of liraglutide and IS in the brain tissueBack to article page